EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management

Mats I Nilsson iD, Donald Xhuti, Nicoletta Maria de Maat, Bart P Hettinga, Mark A Tarnopolsky iD

Nutrients · 23.12.2024 · 16 (24) · 4407

DOI: 10.3390/nu16244407 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 23.12.2024. Verfasst von Mats I Nilsson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Exerkine Corporation, McMaster University Medical Center, Hamilton, ON L8N 3Z5, Canada. Hauptthemen laut MEDLINE: Obesity, Dietary Supplements, Resistance Training, Sarcopenia. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anabolic resistance accelerates muscle loss in aging and obesity, thus predisposing to sarcopenic obesity.

Methods

In this retrospective analysis of a randomized clinical trial, we examined baseline predictors of the adaptive response to three months of home-based resistance exercise, daily physical activity, and protein-based, multi-ingredient supplementation (MIS) in a cohort of free-living, older males (n = 32).

Results

Multiple linear regression analyses revealed that obesity and a Global Risk Index for metabolic syndrome (MetS) were the strongest predictors of Δ% gains in lean mass (TLM and ASM), LM/body fat ratios (TLM/%BF, ASM/FM, and ASM/%BF), and allometric LM (ASMI, TLM/BW, TLM/BMI, ASM/BW), with moderately strong, negative correlations to the adaptive response to polytherapy r = −0.36 to −0.68 (p < 0.05). Kidney function, PA level, and chronological age were only weakly associated with treatment outcomes (p > 0.05). Next, we performed a subgroup analysis in overweight/obese participants with at least one other MetS risk factor and examined their adaptive response to polytherapy with two types of protein-based MIS (PLA; collagen peptides and safflower oil, n = 8, M5; whey/casein, creatine, calcium, vitamin D3, and fish oil, n = 12). The M5 group showed greater improvements in LM (ASM; +2% vs. −0.8%), LM/body fat ratios (ASM/FM; +3.8% vs. −5.1%), allometric LM (ASM/BMI; +1.2% vs. −2.5%), strength (leg press; +17% vs. −1.4%), and performance (4-Step-Stair-Climb time; −10.5% vs. +1.1%) vs. the PLA group (p < 0.05). Bone turnover markers, indicative of bone accretion, were increased pre-to-post intervention in the M5 group only (P1NP; p = 0.036, P1NP/CTX ratio; p = 0.088). The overall anabolic response, as indicated by ranking low-to-high responders for Δ% LM (p = 0.0079), strength (p = 0.097), and performance (p = 0.19), was therefore significantly higher in the M5 vs. PLA group (p = 0.013).

Conclusions

Our findings confirm that obesity/MetS is a key driver of anabolic resistance in old age and that a high-quality, whey/casein-based MIS is more effective than a collagen-based alternative for maintaining musculoskeletal health in individuals at risk for sarcopenic obesity, even when total daily protein intake exceeds current treatment guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityDietary SupplementsResistance TrainingSarcopeniaDietary ProteinsAgingHumansMaleRetrospective StudiesAgedMiddle AgedBody CompositionMetabolic DiseasesMetabolic Syndrome

Stichwörter der Autor:innen

GLP-1Ozempicaginganabolic resistancecalciumcollagencreatineexercisemetabolic syndromeobesityomega-3proteinsarcopeniasarcopenic obesityvitamin D

Substanzen

Dietary Proteins

Autor:innen und Institutionen

  • Exerkine Corporation, McMaster University Medical Center, Hamilton, ON L8N 3Z5, Canada.
  • Department of Pediatrics, McMaster University Medical Center, Hamilton, ON L8N 3Z5, Canada.

ORCID-Profile: Mats I Nilsson, Mark A Tarnopolsky

Förderung

  • CIHR

Zitieren

APA

Nilsson, M. I., Xhuti, D., de Maat, N. M., Hettinga, B. P., & Tarnopolsky, M. A. (2024). Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management. Nutrients, 16(24), 4407. https://doi.org/10.3390/nu16244407

Vancouver

Nilsson MI, Xhuti D, de Maat NM, Hettinga BP, Tarnopolsky MA. Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management. Nutrients. 2024;16(24):4407. doi:10.3390/nu16244407

BibTeX
@article{Nilsson2024,
  author = {Nilsson, Mats I and Xhuti, Donald and de Maat, Nicoletta Maria and Hettinga, Bart P and Tarnopolsky, Mark A},
  title = {Obesity and Metabolic Disease Impair the Anabolic Response to Protein Supplementation and Resistance Exercise: A Retrospective Analysis of a Randomized Clinical Trial with Implications for Aging, Sarcopenic Obesity, and Weight Management},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {24},
  pages = {4407},
  doi = {10.3390/nu16244407}
}
Kostenlos starten →